Abstract:Viral vectors made from adeno-associated virus (AAV) have emerged as preferred tools in basic and translational neuroscience research to introduce or modify genetic material in cells of interest. The use of viral vectors is particularly attractive in nontransgenic species, such as nonhuman primates. Injection of AAV solutions into the cerebrospinal fluid is an effective method to achieve a broad distribution of a transgene in the central nervous system. In this study, we conducted injections of AAV9-PHP.B, a recently described AAV capsid mutant, in the lateral ventricle of mice and rhesus macaques. To enhance the expression of the transgene (the tag protein emerald green fluorescent protein [EmGFP]), we used a gene promoter that confers high neuron-specific expression of the transgene, the human synapsin 1 (SYN1) promoter. The efficacy of the viral vector was first tested in mice. Our results show that intracerebroventricular injections of AAV9-PHP.B SYN1-EmGFP-woodchuck hepatitis virus posttranscriptional regulatory element resulted in neuronal EmGFP expression throughout the mice and monkey brains. We have provided a thorough characterization of the brain regions expressing EmGFP in both species. EmGFP was observed in neuronal cell bodies over the whole cerebral cortex and in the cerebellum, as well as in some subcortical regions, including the striatum and hippocampus. We also observed densely labeled neuropil in areas known to receive projections from these regions. Double fluorescence studies demonstrated that EmGFP was expressed by several types of neurons throughout the mouse and monkey brain. Our results demonstrate that a single injection in the lateral ventricle is an efficient method to obtain transgene expression in many cortical and subcortical regions, obviating the need of multiple intraparenchymal injections to cover large brain areas. The use of intraventricular injections of AAV9-PHP.B SYN1-EmGFP could provide a powerful approach to transduce widespread areas of the brain and may contribute to further development of methods to genetically target-specific populations of neurons.

Functional enhancer elements drive subclass-selective expression from mouse to primate neocortex

Viral Manipulation of Functionally Distinct Neurons from Mice to Humans

Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans

An enhancer-AAV toolbox to target and manipulate distinct interneuron subtypes

Enhancer AAVs for targeting spinal motor neurons and descending motor pathways in rodents and macaque

Cell Type Specific Enhancers for Dorsolateral Prefrontal Cortex.

Enhancer-AAVs allow genetic access to oligodendrocytes and diverse populations of astrocytes across species

A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types

Enhancer AAV toolbox for accessing and perturbing striatal cell types and circuits

Preferential transduction of parvalbumin-expressing cortical neurons by AAV-mDLX5/6 vectors

Functional gene delivery to and across brain vasculature of systemic AAVs with endothelial-specific tropism in rodents and broad tropism in primates

Massively parallel in vivo Perturb-seq reveals cell-type-specific transcriptional networks in cortical development

Cis-regulatory elements driving motor neuron-restricted viral payload expression within the mammalian spinal cord

Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System

Laminar specificity and coverage of viral-mediated gene expression restricted to GABAergic interneurons and their parvalbumin subclass in marmoset primary visual cortex

Identification of cis-regulatory modules for adeno-associated virus-based cell-type-specific targeting in the retina and brain

Enhanced AAV transduction across preclinical CNS models: A comparative study in human brain organoids with cross-species evaluations

Identification of neuron-type specific promoters in monkey genome and their functional validation in mice

Generation of an enhancer-driven gene expression viral tool specific to dentate granule cell-types through direct hippocampal injection

Common AAV gene therapy vectors show indiscriminate transduction of living human brain cell types